(Q35153987)

6 August 2017

1 reference

title

Preventing long term complications. Implications for combination therapy with acarbose (English)

1 reference

glycoside hydrolase inhibitors

6 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1280578

8 September 2022

author name string

B. R. Zimmerman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1280578

8 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1280578

8 September 2022

publication date

1 January 1992

1 reference

6 August 2017

1 reference

6 August 2017

44 Suppl 3

1 reference

6 August 2017

54-60

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199200443-00008

6 August 2017

0 references

cites work

Insulin and Cardiovascular Disease: Paris Prospective Study

1 reference

12 December 2020

Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

1 reference

12 December 2020

Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group

1 reference

12 December 2020

Metabolic effects of acarbose in young healthy men.

1 reference

12 December 2020

Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients.

1 reference

12 December 2020

Influence of the degree of control of diabetes on the prevention, postponement and amelioration of late complications

1 reference

12 December 2020

Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models

1 reference

12 December 2020

Effects of acarbose on serum lipoproteins in healthy individuals during prolonged administration of a fiber-free formula diet

1 reference

12 December 2020

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement

1 reference

12 December 2020

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

1 reference

12 December 2020

Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations

1 reference

12 December 2020

Progression of incipient diabetic retinopathy during good glycemic control.

1 reference

12 December 2020

Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitors

1 reference

12 December 2020

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

12 December 2020

Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland

1 reference

12 December 2020

Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDM.

1 reference

12 December 2020

Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas.

1 reference

12 December 2020

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

12 December 2020

Current status of aldose reductase inhibitors

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

Acarbose treatment and diabetic nephropathy in the Cohen diabetic rat.

1 reference

12 December 2020

Detection of pancreatic islet tissue following islet allotransplantation in man

1 reference

12 December 2020

A prospective study of peripheral occlusive arterial disease in diabetes. III. Initial lipid and lipoprotein findings.

1 reference

12 December 2020

Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. American Diabetes Association

1 reference

12 December 2020

Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications

1 reference

12 December 2020

10.2165/00003495-199200443-00008

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference